Scarica l'app Stockscreener
6.08
6.11%
0.35
Dopo l'orario di chiusura:
6.00
-0.08
-1.32%
Precedente Chiudi:
$5.73
Aprire:
$6
Volume 24 ore:
21,890
Relative Volume:
1.38
Capitalizzazione di mercato:
$23.83M
Reddito:
-
Utile/perdita netta:
$-14.56M
Rapporto P/E:
-0.3615
EPS:
-16.82
Flusso di cassa netto:
$-12.46M
1 W Prestazione:
+7.23%
1M Prestazione:
+0.52%
6M Prestazione:
+7.61%
1 anno Prestazione:
+89.41%
Intervallo 1D:
$5.616
$6.35
Intervallo di 1 settimana:
$5.34
$6.75
Portata 52W:
$2.80
$7.89
Tenax Therapeutics Inc Stock (TENX) Company Profile
Nome
Tenax Therapeutics Inc
Settore
Industria
Telefono
919-855-2100
Indirizzo
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Confronta TENX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
6.08 | 23.83M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.82 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
520.29 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.82 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.53 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
267.12 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-24 | Iniziato | Leerink Partners | Outperform |
| 2024-10-14 | Iniziato | Guggenheim | Buy |
| 2024-09-30 | Iniziato | William Blair | Outperform |
| 2017-05-18 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Iniziato | MLV & Co | Buy |
| 2014-11-18 | Iniziato | WallachBeth | Buy |
Mostra tutto
Tenax Therapeutics Inc Borsa (TENX) Ultime notizie
Tenax Therapeutics Approves Officer Exculpation Amendment - TipRanks
Two Sigma Investments LP Acquires Shares of 13,521 Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Millennium Management LLC Acquires New Holdings in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
When (TENX) Moves Investors should Listen - news.stocktradersdaily.com
Where are the Opportunities in (TENX) - news.stocktradersdaily.com
Tectonic, Tenax, others aim for shift in heart failure - BioWorld MedTech
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments - TipRanks
Roth Capital Issues Negative Forecast for TENX Earnings - Defense World
William Blair Cuts Earnings Estimates for Tenax Therapeutics - Defense World
Leerink Partnrs Brokers Boost Earnings Estimates for TENX - Defense World
(TENX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
What is William Blair’s Estimate for TENX FY2028 Earnings? - Defense World
Roth Capital Has Bearish Forecast for TENX FY2028 Earnings - Defense World
Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com - Defense World
Tenax Therapeutics: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX S - GuruFocus
Analyst Adjusts Tenax Therapeutics (TENX) Price Target, Maintains Buy Rating | TENX Stock News - GuruFocus
Tenax Therapeutics (TENX) Advances Phase 3 Studies in 2025 | TEN - GuruFocus
Tenax Therapeutics Inc Reports Q1 2025 Net Loss of $10.4 Million Amid Rising R&D and Administrative Expenses - GuruFocus
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX Stock News - GuruFocus
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Tenax Advances Breakthrough PH-HFpEF Treatment: Phase 3 Trial Updates and $111M War Chest Revealed - Stock Titan
Tenax Therapeutics (TENX) Projected to Post Earnings on Tuesday - Defense World
(TENX) Technical Data - news.stocktradersdaily.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com - Defense World
Geode Capital Management LLC Boosts Stock Position in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com - Defense World
Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN
SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow
Form DEF 14A TENAX THERAPEUTICS, INC. For: Apr 24 - StreetInsider
Tenax Therapeutics Advances Cardiopulmonary Therapies - TipRanks
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - The Globe and Mail
Oxygen Biotherapeutics, Inc. : Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast - marketscreener.com
Teanx Therapeutics plans secondary offering - MSN
Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
Tenax Therapeutics (TENX) Files Prospectus for Stock Resale - GuruFocus
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Exclusive: Tenax Leadership Team to Unveil Latest Phase 3 Progress at Major Healthcare Conference - Stock Titan
What is Leerink Partnrs’ Forecast for TENX Q1 Earnings? - Defense World
Equities Analysts Offer Predictions for TENX Q1 Earnings - Defense World
Q1 Earnings Estimate for TENX Issued By William Blair - Defense World
Tenax Therapeutics (NASDAQ:TENX) Earns Sell Rating from Analysts at StockNews.com - Defense World
Research Analysts Set Expectations for TENX Q1 Earnings - Defense World
Tenax Therapeutics Inc Azioni (TENX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.06%
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):